BNN — BRAIN Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €83.46m
- €83.46m
- €56.23m
- 39
- 20
- 41
- 22
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -10.5 | -9.02 | -4.68 | -6.34 | -8.11 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -0.153 | -0.998 | -4.82 | -3.07 | -1.35 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.88 | 1.29 | 1.34 | 3.64 | 0.139 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.38 | -4.77 | -3.91 | -1.49 | -4.22 |
Capital Expenditures | -6.64 | -2.86 | -1.26 | -6.08 | -2.64 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.106 | -1.61 | -0.918 | -6.6 | 3.2 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6.74 | -4.47 | -2.18 | -12.7 | 0.562 |
Financing Cash Flow Items | 0.006 | 14.6 | 14.4 | 0 | -9.59 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.276 | 13.1 | 11.6 | -1.97 | 0.459 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.4 | 3.78 | 5.6 | -16.1 | -3.09 |